MedTrace Logo

Characterizing the Intestinal Hormonal Secretion in Non-obese, Obese and Non-obese Patients After Bariatric Surgery

NCT03399097 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-07-20

No results posted yet for this study

Summary

The enteroendocrine system is composed from different cells along the different parts of the gastrointestinal tract, secreting diverse hormones and bariatric surgery alters intestinal hormone secretion, affecting glycemic control and weight. The aim of the study is to characterize the composition and secretory profile of enteroendocrine cells in the obese, non-obese and non-obese post bariatric surgery.

Conditions

Sponsors & Collaborators

  • Hadassah Medical Organization

    collaborator OTHER

  • Dr. Ofir Harnoy MD

    lead OTHER_GOV

Principal Investigators

  • Amir Tirosh, MD, PhD · Sheba Medical Center

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2018-12-31
Completion
2020-07-16

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03399097 on ClinicalTrials.gov